Therapeutics for diabetes mellitus

Details Therapeutics for diabetes mellitus Therapeutics for diabetes mellitus

A - Human Necessities

61

K

A61K 38/25 (2006.01) A61K 38/17 (2006.01) A61P 3/04 (2006.01) A61P 3/10 (2006.01)

Patent

CA 2493906

It is intended to provide a preventive or a remedy for diabetes which contains as the active ingredient a growth hormone secretagogue receptor (GHS-R) antagonist; a method of lowering blood glucose level characterized by comprising administering a GHS-R antagonist; a preventive or a remedy for obesity which contains as the active ingredient a GHS-R antagonist; and an appetite controlling agent which contains as the active ingredient a GHS-R antagonist.

L'invention concerne une substance prophylactique ou thérapeutique qui contient comme principe actif un récepteur de secretagogue d'hormone de croissance (GHS-R) ; une méthode de réduction de la glycémie qui consiste à administrer un antagoniste du GHS-R ; une substance prophylactique ou thérapeutique contre l'obésité qui renferme comme principe actif un antagoniste de GHS-R; et enfin, un modérateur d'appétit qui renferme comme principe actif un antagoniste de GHS-R.

Affiliated with

Also associated with

Rating

Therapeutics for diabetes mellitus does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutics for diabetes mellitus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutics for diabetes mellitus will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1548638